MX2024009646A - Métodos de pérdida de peso y preservación de la masa muscular esquelética. - Google Patents

Métodos de pérdida de peso y preservación de la masa muscular esquelética.

Info

Publication number
MX2024009646A
MX2024009646A MX2024009646A MX2024009646A MX2024009646A MX 2024009646 A MX2024009646 A MX 2024009646A MX 2024009646 A MX2024009646 A MX 2024009646A MX 2024009646 A MX2024009646 A MX 2024009646A MX 2024009646 A MX2024009646 A MX 2024009646A
Authority
MX
Mexico
Prior art keywords
weight loss
skeletal muscle
muscle mass
preservation
methods
Prior art date
Application number
MX2024009646A
Other languages
English (en)
Spanish (es)
Inventor
Shaharyar Khan
Diane Jorkasky
Francisco Portell
Original Assignee
Rivus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rivus Pharmaceuticals Inc filed Critical Rivus Pharmaceuticals Inc
Publication of MX2024009646A publication Critical patent/MX2024009646A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MX2024009646A 2022-02-07 2024-08-05 Métodos de pérdida de peso y preservación de la masa muscular esquelética. MX2024009646A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307506P 2022-02-07 2022-02-07
US202263382456P 2022-11-04 2022-11-04
PCT/US2023/062077 WO2023150767A1 (en) 2022-02-07 2023-02-06 Methods of weight loss and preserving skeletal muscle mass

Publications (1)

Publication Number Publication Date
MX2024009646A true MX2024009646A (es) 2024-11-08

Family

ID=85556813

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2024009646A MX2024009646A (es) 2022-02-07 2024-08-05 Métodos de pérdida de peso y preservación de la masa muscular esquelética.

Country Status (12)

Country Link
US (1) US20250134864A1 (cg-RX-API-DMAC7.html)
EP (1) EP4475841A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025505187A (cg-RX-API-DMAC7.html)
KR (1) KR20240146052A (cg-RX-API-DMAC7.html)
AU (1) AU2023216366A1 (cg-RX-API-DMAC7.html)
CA (1) CA3243640A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024002341A1 (cg-RX-API-DMAC7.html)
GE (1) GEAP202416578A (cg-RX-API-DMAC7.html)
IL (1) IL314684A (cg-RX-API-DMAC7.html)
JO (1) JOP20240177A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024009646A (cg-RX-API-DMAC7.html)
WO (1) WO2023150767A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025199516A1 (en) * 2024-03-22 2025-09-25 Board Of Regents, The University Of Texas System Compositions and methods for preserving or increasing lean muscle mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo

Also Published As

Publication number Publication date
JP2025505187A (ja) 2025-02-21
AU2023216366A1 (en) 2024-08-15
GEAP202416578A (en) 2024-11-11
IL314684A (en) 2024-10-01
CL2024002341A1 (es) 2025-01-17
WO2023150767A1 (en) 2023-08-10
CA3243640A1 (en) 2023-08-10
KR20240146052A (ko) 2024-10-07
JOP20240177A1 (ar) 2024-08-04
EP4475841A1 (en) 2024-12-18
US20250134864A1 (en) 2025-05-01

Similar Documents

Publication Publication Date Title
CO2022005629A2 (es) Micelios comestibles y métodos de elaboración de los mismos
MY209267A (en) Compositions and methods of use of -hydroxy--methylbutyrate (hmb) assosiated with intermittent fasting
Ponton et al. Variation of the outer circumferential layer in the limb bones of birds
MY175478A (en) Muscle training method
CL2024002341A1 (es) Métodos de pérdida de peso y preservación de la masa muscular esquelética
AR117184A1 (es) Composiciones herbicidas para tierras de pastoreo y métodos para aplicar las mismas
WO2021113401A3 (en) Histone deacytlase 6 modulation of titin protein mediated cardiac tissue stiffness and method for same
CO2020014307A2 (es) Producto alimenticio nutricional y métodos relacionados
ATE268122T1 (de) Verfahren zur selektiven veränderung des körperfettgehaltes, der futterverwendung oder der gewichtszunahme
Kozlovskaya et al. New approaches to countermeasures of the negative effects of microgravity in long-term space flights
MX2021013777A (es) Mezcla nutricional a base de mct para proporcionar beneficios para la salud en animales.
Eleckuvan Effectiveness of fartlek training on maximum oxygen consumption and resting pulse rate
ES2114532T3 (es) Producto de reposteria y procedimiento para mejorar la adherencia de recubrimientos basados en grasas a productos de reposteria congelados basados en grasas.
MX2021009862A (es) Metodos para obtener celulas de musculo liso inducidas.
EA201892129A1 (ru) Фунгицидная композиция
Bansil ROLE OF PROSTAGLANDINS E AND F2 ALPHA IN EXERCISE INDUCED DELAYED MUSCLE SORENESS.
IT202200017220A1 (it) Composizione per la realizzazione di un modello per la simulazione di un tessuto molle cerebrale, metodo di realizzazione di un modello e uso
MX2022006829A (es) Formulacion que comprende strreptomyces spp. para uso en tratamiento de semillas.
PH22018001191U1 (en) Small rock oyster (sacosstrea sp.) sauce
EP4167761A4 (en) COMPOSITIONS AND METHODS OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE (HMB) TO IMPROVE MUSCLE MASS, STRENGTH AND FUNCTION WITHOUT EXERCISE
TH26325U (th) ซอสผัดไทย
TH26325Y (th) ซอสผัดไทย
PH22019000897U1 (en) Composition of peanut crunch
GB202202233D0 (en) Methods of leather working and products produced thereby
TR202105425U5 (tr) Egzersi̇z seti̇